Local News: Ashburn, VA 

 | 

Sign Up

 | 

Sign In

St Jude Medical

St Jude Medical Newswire (Page 2)

Comprehensive Real-Time News Feed for St Jude Medical. (Page 2)

Results 21 - 40 of 457 in St Jude Medical

  1. BIOLASE Adds Two New Independent Directors to Its BoardRead the original story

    Monday Jun 10 | Freshnews

    Dr. Moll and Ms. Enright were each determined to be independent under the Nasdaq Listing Standards by the Company's Board and met the requirements for committee assignments as set forth in the respective committee charters.

    Comment?

  2. St. Jude's Durata backed by doctor who found Riata defect, Bloomberg saysRead the original story

    Tuesday May 28 | Theflyonthewall.com

    St. Jude invests $40M in Spinal Modulation, gets exclusive option to acquire St. Jude Medical and privately-held Spinal Modulation announced that they have entered into a series of agreements under which St. Jude Medical made a $40M equity investment in Spinal Modulation, a company that has developed an innovative neuromodulation therapy that ... (more)

    Comment?

  3. St. Jude Invests in Spinal Cord Stimulation for Pain ManagementRead the original story

    Sunday Jun 9 | The Motley Fool

    Normal neural activity results from a balance of electrical and chemical signals that are vulnerable to disruption by trauma to the nervous system.

    Comment?

  4. Zimmer Holdings Inc. Is A Decent BuyRead the original story

    Sunday Jun 9 | Seeking Alpha

    Zimmer Holdings, Inc. is operating in medical device industry; the global medical device industry is recession-resilient and profitable.

    Comment?

  5. St. Jude's Durata lead backed by doctor who found flaws with earlier heart deviceRead the original story

    Friday Jun 7 | Star Tribune

    Ernest Lau, a cardiologist at the Royal Victoria Hospital in Belfast, Ireland, was one of the first doctors to identify a defect in St. Jude Medical Inc.'s Riata that led to its recall in 2011.

    Comment?

  6. St. Jude's Durata Backed by Doctor Who Found Riata FlawsRead the original story

    Friday Jun 7 | The Washington Post

    Ernest Lau, a cardiologist at the Royal Victoria Hospital in Belfast, Ireland, was one of the first doctors to identify a defect in St. Jude Medical Inc.'s Riata that led to its recall in 2011.

    Comment?

  7. St. Jude invests $40M in chronic-pain device startupRead the original story

    Friday Jun 7 | Business Journal

    St. Jude Medical has invested $40 million in Spinal Modulation, a California company developing a spinal-cord stimulator that treats chronic pain.

    Comment?

  8. St. Jude Medical expands in pain-management technologyRead the original story

    Friday Jun 7 | TwinCities

    Little Canada-based St. Jude Medical has invested $40 million in a California medical device manufacturer as part of a deal that could evolve into a $300 million acquisition by St. Jude down the road.

    Comment?

  9. St. Jude Medical Makes $40 Million Investment and Obtains Option to Buy Spinal ModulationRead the original story w/Photo

    Friday Jun 7 | Medical Device/Diagnostic Ind.

    St. Jude Medical announced Friday that it is making a $40 million investment in a California spinal company and has also reserved the option to buy it at a later date for no more than $300 million.

    Comment?

  10. Agree To Buy St. Jude Medical At $35, Earn 8.4%Read the original story w/Photo

    Friday Jun 7 | Forbes.com

    Investors eyeing a purchase of St. Jude Medical, Inc. stock, but cautious about paying the going market price of $43.77/share, might benefit from considering selling puts among the alternative strategies at their disposal.

    Comment?

  11. St. Jude Medical Signs Equity Investment and Option to Purchase Agreement with Spinal ModulationRead the original story

    Friday Jun 7 | Business Wire

    Agreement provides St. Jude Medical immediate international distribution rights for the Axium Neurostimulator System and a longer-term exclusive option to acquire the company ST.

    Comment?

  12. St. Jude invests $40M in Spinal Modulation, gets exclusive option to acquireRead the original story

    Tuesday May 28 | Theflyonthewall.com

    St. Jude invests $40M in Spinal Modulation, gets exclusive option to acquire St. Jude Medical and privately-held Spinal Modulation announced that they have entered into a series of agreements under which St. Jude Medical made a $40M equity investment in Spinal Modulation, a company that has developed an innovative neuromodulation therapy that ... (more)

    Comment?

  13. Investors Should Assign A Fair Value Range To St. JudeRead the original story

    Thursday Jun 6 | Seeking Alpha

    One of the biggest fallacies that investors have is that they believe that a stock is worth precisely this, or a company's shares are worth precisely that.

    Comment?

  14. Medtronic: CoreValve's Long Road To U.S. ApprovalRead the original story

    Wednesday Jun 5 | Seeking Alpha

    Since its European approval in 2007, Medtronic's CoreValve System has been implanted in more than 40,000 patients in 60 countries.

    Comment?

  15. St. Jude Medical Given "Underperform" Rating at RBC CapitalRead the original story

    Tuesday Jun 4 | AmericanBankingNews.com

    's stock had its "underperform" rating restated by equities researchers at RBC Capital in a research report issued on Tuesday, Stock Ratings Network reports.

    Comment?

  16. St. Jude Medical Stock Rating Reaffirmed by TheStreetRead the original story

    Tuesday Jun 4 | AmericanBankingNews.com

    ... at TheStreet in a note issued to investors on Tuesday, Analyst Ratings.Net reports. The analysts wrote, "St Jude Medical (STJ) has been reiterated by TheStreet Ratings as a buy with a ratings score of B+. The company's strengths can be seen in ...

    Comment?

  17. Online journal raises new concerns over St. Jude leadRead the original story

    Tuesday Jun 4 | Star Tribune

    A report involving a failed Durata defibrillator lead has been published in an online journal, renewing buzz that St. Jude Medical 's newest defibrillator wires may suffer some of the same problems as the Little Canada company's failed and recalled Riata leads.

    Comment?

  18. St. Jude Medical's "Underperform" Rating Reaffirmed at RBC CapitalRead the original story

    Tuesday Jun 4 | Daily Political

    's stock had its "underperform" rating reaffirmed by research analysts at RBC Capital in a report released on Tuesday, StockRatingsNetwork reports.

    Comment?

  19. An online journal raises new concerns over St. Jude lead.Read the original story

    Tuesday Jun 4 | Star Tribune

    A report involving a failed Durata defibrillator lead has been published in an online journal, renewing buzz that St. Jude Medical 's newest defibrillator wires may suffer some of the same problems as the Little Canada company's failed and recalled Riata leads.

    Comment?

  20. Another Negative Report Surfaces About St. Jude's Durata ICD Lead Fueling Concerns About SafetyRead the original story

    Tuesday Jun 4 | Medical Device/Diagnostic Ind.

    The study entitled, "Electrical Failure of an ICD Lead due to a Presumed Insulation Defect Only Diagnosed by a Maximum Output Shock" tells the experience of a 55-year-old male who experienced a single shock and device vibration.

    Comment?